跳至主要内容
临床试验/NCT06545838
NCT06545838招募中不适用

Renin Levels as Prognostic Indicators of Septic Shock Severity and Outcome: Prospective Cohort Study (SOS Trial)

Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Correlation between blood renin concentration and norepinephrine dosage

研究概览

简要总结

The Surviving Sepsis Campaign (SSC) of 2021 characterizes sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection, with a mortality rate of over 30%, which increases to 40% or more in the case of septic shock. Although concept of sepsis has improved, significant gaps remain in assessing its clinical severity and predicting patient outcomes.

Recognized markers of the severity of septic shock are procalcitonin (PCT), presepsin, and, to a certain extent, lactate. Elevated lactate levels result from a shift to anaerobic glycolysis and indicate inadequate oxygen delivery to tissues. Despite the importance of procalcitonin in the course of sepsis, it has proven to be a suboptimal diagnostic biomarker for the development of sepsis, with sensitivity and specificity below 80%. As a result, the use of procalcitonin in addition to clinical assessment to determine the indications for initiating antibiotic therapy is not recommended. Meanwhile, presepsin, although a potential biomarker for the early diagnosis of sepsis, also has only moderate accuracy according to current data and cannot be used as the only test for the diagnosis of sepsis.

Renin is a crucial enzyme in the renin-angiotensin-aldosterone system (RAAS), which plays an important role in the regulation of blood pressure, tissue perfusion, and the balance of water and electrolytes. Thus, renin may be the sensitive biomarker with good prognostic qualities in the context of sepsis and septic shock. Preliminary studies have indicated that elevated renin levels may act as an indicator of patient severity, and could also be used as a marker for the development of septic shock and mortality prognosis.

This study aims to address these gaps by investigating the role of renin as a biomarker for the severity of sepsis and septic shock, focusing on its potential for more accurate prediction of clinical outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Hospitalization in the intensive care unit
  • Confirmed diagnosis of Sepsis within 24 hours
  • Signed informed consent or a decision by the medical council to include the patient in the study

排除标准

  • Any surgical intervention on the kidneys and/or adrenal glands performed within 28 days prior to the patient's inclusion in the study
  • Patients previously included in this study

结局指标

主要结局

Correlation between blood renin concentration and norepinephrine dosage

时间窗: Through study completion, an average of 2 years

A correlation analysis with the calculation of the correlation strength. The degree of correlation ranges from 0 to 1. The closer the correlation coefficient is to one, the stronger the correlation.

次要结局

  • Correlation between blood renin concentration and blood procalcitonin concentration(Through study completion, an average of 2 years)
  • Correlation between blood renin concentration and peripheral blood flow(Through study completion, an average of 2 years)
  • Correlation between blood renin concentration and SOFA score(Through study completion, an average of 2 years)
  • Correlation between blood renin concentration and renal replacement therapy free days(Through study completion, an average of 2 years)
  • Correlation between blood renin concentration and blood lactate concentration(Through study completion, an average of 2 years)
  • 28-days mortality(28 days)
  • Frequency of Major Adverse Kidney Events (MAKE)(28 days)

研究者

发起方
Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Valery Likhvantsev

MD, PhD

Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology

研究点 (1)

Loading locations...

相似试验